To further validate the role of DNA methylation in regulating SORT1 expression, we treated HCC cells with the methylation inhibitor 5-aza-2’-deoxycytidine (5-aza) at a concentration of 5 μM for 48 h. Here, SORT1 is linked to hepatocellular carcinoma.